entinostat trials for Breast cancer

All entinostat trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying entinostat for Breast cancer

• A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine Therapy
  NCT07330544 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer
  NCT07492394 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure
  NCT07708194 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location

Common questions

How many trials study entinostat for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.